{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:56Z","timestamp":1793814116219,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mumio (Shilajit) is a traditional medicinal drug known and used for hundreds of years. Bladder cancer is one of the most common cancer types and better treatments are needed. This study analysed the in vitro effect of Mumio on urinary bladder cancer cells (T24 and 5637) in comparison to normal uroepithelial cells (SV-HUC1). Cytotoxicity of Mumio was analysed in these cell lines via MTT and real-time cell growth assays as well via the assessment of the cytoskeleton, apoptosis, and cell cycle. Mumio affected the viability of both cell types in a time and concentration dependent manner. We observed a selectivity of Mumio against cancer cells. Cell cycle and apoptosis analysis showed that Mumio inhibited G0\/G1 or S phase cell cycle, which in turn induced apoptosis. Our results showed that Mumio was significantly more cytotoxic to urinary bladder cancer cells than to normal cells. These results are promising and indicate Mumio as a great candidate for urinary bladder cancer treatment and further investigations should be performed.<\/jats:p>","DOI":"10.1038\/s41598-021-01996-8","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T11:03:26Z","timestamp":1637319806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment"],"prefix":"10.1038","volume":"11","author":[{"given":"T.","family":"Kloskowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Szeliski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Krzeszowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Fekner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141.","family":"Kazimierski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jundzi\u0142\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Drewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pokrywczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"1996_CR1","doi-asserted-by":"publisher","first-page":"674142","DOI":"10.1155\/2012\/674142","volume":"2012","author":"C Carrasco-Gallardo","year":"2012","unstructured":"Carrasco-Gallardo, C., Guzman, L. & Maccioni, R. B. Shilajit: A natural phytocomplex with potential procognitive activity. Int. J. Alzheimer\u2019s Dis. 2012, 674142\u2013674142. https:\/\/doi.org\/10.1155\/2012\/674142 (2012).","journal-title":"Int. J. Alzheimer's Dis."},{"key":"1996_CR2","first-page":"260","volume-title":"Medicinal Plants in Australia","author":"W Cheryll","year":"2013","unstructured":"Cheryll, W. Medicinal Plants in Australia Vol. 4, 260\u2013261 (Rosenberg Publishing Pty Ltd, 2013)."},{"key":"1996_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tca.2003.09.034","volume":"417","author":"A Garedew","year":"2004","unstructured":"Garedew, A., Feist, M., Schmolz, E. & Lamprecht, I. Thermal analysis of mumiyo, the legendary folk remedy from the Himalaya region. Thermochim. Acta 417, 301\u2013309. https:\/\/doi.org\/10.1016\/j.tca.2003.09.034 (2004).","journal-title":"Thermochim. Acta"},{"key":"1996_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ptr.2650050505","volume":"5","author":"S Ghosal","year":"1991","unstructured":"Ghosal, S. et al. The need for formulation of shilajit by its isolated active constituents. Phytother. Res. 5, 211\u2013216. https:\/\/doi.org\/10.1002\/ptr.2650050505 (1991).","journal-title":"Phytother. Res."},{"key":"1996_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nen072","author":"A Aiello","year":"2011","unstructured":"Aiello, A. et al. Mumijo traditional medicine: Fossil deposits from Antarctica (Chemical composition and beneficial bioactivity). Evid. Based Complement. Altern. Med. https:\/\/doi.org\/10.1093\/ecam\/nen072 (2011).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"1996_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/jad-2011-110623","volume":"27","author":"A Cornejo","year":"2011","unstructured":"Cornejo, A., Jimenez, J. M., Caballero, L., Melo, F. & Maccioni, R. B. Fulvic Acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer\u2019s disease. J. Alzheimers Dis. 27, 143\u2013153. https:\/\/doi.org\/10.3233\/jad-2011-110623 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"1996_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ptr.2650020408","volume":"2","author":"S Ghosal","year":"1988","unstructured":"Ghosal, S. et al. Anti-ulcerogenic activity of fulvic acids and 4\u2032-methoxy-6-carbomethoxybiphenyl isolated from shilajit. Phytother. Res. 2, 187\u2013191. https:\/\/doi.org\/10.1002\/ptr.2650020408 (1988).","journal-title":"Phytother. Res."},{"key":"1996_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ddr.10058","volume":"57","author":"I Schepetkin","year":"2002","unstructured":"Schepetkin, I., Khlebnikov, A. & Kwon, B. S. Medical drugs from humus matter: Focus on mumie. Drug Dev. Res. 57, 140\u2013159. https:\/\/doi.org\/10.1002\/ddr.10058 (2002).","journal-title":"Drug Dev. Res."},{"key":"1996_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/s2221-1691(12)60043-4","volume":"2","author":"C Velmurugan","year":"2012","unstructured":"Velmurugan, C., Vivek, B., Wilson, E., Bharathi, T. & Sundaram, T. Evaluation of safety profile of black shilajit after 91 days repeated administration in rats. Asian Pac. J. Trop. Biomed. 2, 210\u2013214. https:\/\/doi.org\/10.1016\/s2221-1691(12)60043-4 (2012).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"1996_CR10","volume-title":"Mumijo, Das schwarze Gold des Himalaya","author":"W Windmann","year":"2005","unstructured":"Windmann, W. Mumijo, Das schwarze Gold des Himalaya (Windpferd, 2005)."},{"key":"1996_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ptr.2100","volume":"21","author":"SP Agarwal","year":"2007","unstructured":"Agarwal, S. P., Khanna, R., Karmarkar, R., Anwer, M. K. & Khar, R. K. Shilajit: A review. Phytother. Res. 21, 401\u2013405. https:\/\/doi.org\/10.1002\/ptr.2100 (2007).","journal-title":"Phytother. Res."},{"key":"1996_CR12","unstructured":"Galimov, E. M., Kodina, L. A., Vlasova, L. N., Velyukhanova, T. K. & Bazilevskaja, O. L. Geochemistry of mummiyo. Geokhimiya 1494\u20131505 (1986)."},{"key":"1996_CR13","volume-title":"Adaptogens in Medical Herbalism: Elite Herbs and Natural Compounds for Mastering Stress, Aging, and Chronic Disease","author":"DR Yance","year":"2013","unstructured":"Yance, D. R. Adaptogens in Medical Herbalism: Elite Herbs and Natural Compounds for Mastering Stress, Aging, and Chronic Disease (Inner Traditions Bear and Company, 2013)."},{"key":"1996_CR14","first-page":"49","volume":"8","author":"L Frolova","year":"1996","unstructured":"Frolova, L. & Kiseleva, T. Chemical composition of mumie and methods for determination of its authenticity an quality. ChemPharm J 8, 49\u201353 (1996).","journal-title":"ChemPharm J"},{"key":"1996_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ptr.2635","volume":"23","author":"IA Schepetkin","year":"2009","unstructured":"Schepetkin, I. A., Xie, G., Jutilla, M. A. & Quinn, M. T. Complement-fixing activity of fulvic acid from Shilajit and other natural sources. Phytother. Res. 23, 373\u2013384. https:\/\/doi.org\/10.1002\/ptr.2635 (2009).","journal-title":"Phytother. Res."},{"key":"1996_CR16","unstructured":"Cancer, I. A. f. R. o. GLOBOCAN. Cancer Incidence and Mortality Worldwide. http:\/\/gco.iarc.fr\/ (2018)."},{"key":"1996_CR17","unstructured":"Society, A. C. Bladder Cancer\u2014Causes, Risk Factors, and Prevention. https:\/\/www.cancer.org\/cancer\/bladder-cancer\/causes-risks-prevention.html (2019)."},{"key":"1996_CR18","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2019.0453","author":"SMH Sadeghi","year":"2020","unstructured":"Sadeghi, S. M. H. et al. Efficacy of momiai in tibia fracture repair: a randomized double-blinded placebo-controlled clinical trial. J. Altern. Complement. Med. https:\/\/doi.org\/10.1089\/acm.2019.0453 (2020).","journal-title":"J. Altern. Complement. Med."},{"key":"1996_CR19","first-page":"129","volume":"6","author":"NN Andriukhova","year":"1997","unstructured":"Andriukhova, N. N. The treatment of benign prostatic hyperplasia using the Mumie-Vitas preparation. Likars\u2019ka sprava 6, 129\u2013132 (1997).","journal-title":"Likars'ka sprava"},{"key":"1996_CR20","doi-asserted-by":"publisher","first-page":"93279","DOI":"10.18632\/oncotarget.21565","volume":"8","author":"XB Sui","year":"2017","unstructured":"Sui, X. B., Lei, L. M., Chen, L. X., Xie, T. & Li, X. Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget 8, 93279\u201393294. https:\/\/doi.org\/10.18632\/oncotarget.21565 (2017).","journal-title":"Oncotarget"},{"key":"1996_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0278-6915(99)00021-6","volume":"37","author":"KL Khanduja","year":"1999","unstructured":"Khanduja, K. L., Gandhi, R. K., Pathania, V. & Syal, N. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem. Toxicol. 37, 313\u2013318. https:\/\/doi.org\/10.1016\/s0278-6915(99)00021-6 (1999).","journal-title":"Food Chem. Toxicol."},{"key":"1996_CR22","first-page":"431","volume":"17","author":"KC Thresiamma","year":"1998","unstructured":"Thresiamma, K. C., George, J. & Kuttan, R. Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J. Exp. Clin. Cancer Res. 17, 431\u2013434 (1998).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1996_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-016-1131-z","volume":"16","author":"K Pant","year":"2016","unstructured":"Pant, K. et al. Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells. BMC Complement. Altern. Med. 16, 1. https:\/\/doi.org\/10.1186\/s12906-016-1131-z (2016).","journal-title":"BMC Complement. Altern. Med."},{"key":"1996_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14456\/sustj.2008.6","volume":"2","author":"P Thawatchai","year":"2008","unstructured":"Thawatchai, P., Juree, C., Penpun, W., Chutima, L. & Thaksin, S. Some biological activities and safety of mineral pitch. Silpakorn Univ. Sci. Technol. J. 2, 7\u201317. https:\/\/doi.org\/10.14456\/sustj.2008.6 (2008).","journal-title":"Silpakorn Univ. Sci. Technol. J."},{"key":"1996_CR25","first-page":"2167","volume":"32","author":"M Jafari","year":"2019","unstructured":"Jafari, M. et al. Antioxidant, cytotoxic and hyperalgesia-suppressing activity of a native Shilajit obtained from Bahr Aseman mountains. Pak. J. Pharm. Sci. 32, 2167\u20132173 (2019).","journal-title":"Pak. J. Pharm. Sci."},{"key":"1996_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jep.2005.03.011","volume":"101","author":"A Koch","year":"2005","unstructured":"Koch, A., Tamez, P., Pezzuto, J. & Soejarto, D. Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. J. Ethnopharmacol. 101, 95\u201399. https:\/\/doi.org\/10.1016\/j.jep.2005.03.011 (2005).","journal-title":"J. Ethnopharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01996-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:26:34Z","timestamp":1670088394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01996-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01996-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22614"}}